1. Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours;Celsa;J Hepatol,2023
2. Incidence, risk factors and outcomes of checkpoint inhibitor-induced liver injury: a 10-year real-world retrospective cohort study;Atallah;JHEP Rep [Internet],2023
3. Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors;Parlati;JHEP Rep [Internet],2023
4. Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort;Hountondji;JHEP Rep Innov Hepatol,2023
5. Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma;Sangro;J Hepatol,2020